Nephros Inc: Form 10-Q for the period ended Jun 30, 2015
Filed with the SEC on Aug 10, 2015 and accepted by EDGAR at Aug 10, 2015, 16:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-04-01 to 2015-06-30 | $567.0k | us-gaap:SalesRevenueNet |
| Revenue | 6 months2015-01-01 to 2015-06-30 | $1.1m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2015-04-01 to 2015-06-30 | $209.0k | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2015-01-01 to 2015-06-30 | $471.0k | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2015-04-01 to 2015-06-30 | $358.0k | us-gaap:GrossProfit |
| Gross profit | 6 months2015-01-01 to 2015-06-30 | $641.0k | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2015-04-01 to 2015-06-30 | $735.0k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2015-01-01 to 2015-06-30 | $1.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2015-04-01 to 2015-06-30 | −$594.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2015-01-01 to 2015-06-30 | −$1.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-04-01 to 2015-06-30 | $9.0k | us-gaap:InterestExpense |
| Interest expense | 6 months2015-01-01 to 2015-06-30 | $21.0k | us-gaap:InterestExpense |
| Net income | 3 months2015-04-01 to 2015-06-30 | −$1.8m | us-gaap:NetIncomeLoss |
| Net income | 6 months2015-01-01 to 2015-06-30 | −$1.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-04-01 to 2015-06-30 | −$0.06 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2015-01-01 to 2015-06-30 | −$0.05 | us-gaap:EarningsPerShareBasicAndDiluted |
| Basic EPS | 3 months2015-04-01 to 2015-06-30 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2015-01-01 to 2015-06-30 | −$0.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-04-01 to 2015-06-30 | 31,190,714 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2015-01-01 to 2015-06-30 | 30,727,840 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2015-01-01 to 2015-06-30 | −$1.5m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Cash and equivalents | At period end2015-06-30 | $1.0m | us-gaap:Cash |
| Current assets | At period end2015-06-30 | $1.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-06-30 | $3.4m | us-gaap:Assets |
| Current liabilities | At period end2015-06-30 | $1.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-06-30 | $9.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2015-06-30 | −$5.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-15-047743. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.